Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$155.75 - $174.48 $23.8 Million - $26.7 Million
153,116 New
153,116 $23.8 Million
Q2 2022

Aug 11, 2022

BUY
$168.19 - $186.01 $13.1 Million - $14.5 Million
77,940 New
77,940 $13.8 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $6.28 Million - $6.97 Million
-40,263 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $3.87 Million - $4.3 Million
23,965 Added 147.04%
40,263 $6.5 Million
Q2 2021

Aug 12, 2021

BUY
$159.48 - $171.07 $2.6 Million - $2.79 Million
16,298 New
16,298 $2.69 Million
Q3 2020

Nov 06, 2020

SELL
$140.38 - $153.83 $3.79 Million - $4.15 Million
-26,998 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$128.81 - $155.51 $3.48 Million - $4.2 Million
26,998 New
26,998 $3.8 Million
Q4 2019

Feb 12, 2020

SELL
$127.5 - $146.44 $4.62 Million - $5.3 Million
-36,197 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$126.95 - $142.14 $1.79 Million - $2 Million
14,083 Added 63.68%
36,197 $4.68 Million
Q2 2019

Aug 09, 2019

SELL
$131.15 - $144.24 $873,852 - $961,071
-6,663 Reduced 23.15%
22,114 $3.08 Million
Q1 2019

May 13, 2019

BUY
$125.72 - $139.79 $3.62 Million - $4.02 Million
28,777 New
28,777 $4.02 Million
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $2.45 Million - $2.95 Million
-19,937 Closed
0 $0
Q3 2018

Nov 09, 2018

BUY
$121.58 - $142.88 $462,611 - $543,658
3,805 Added 23.59%
19,937 $2.76 Million
Q2 2018

Aug 07, 2018

SELL
$119.4 - $131.76 $765,354 - $844,581
-6,410 Reduced 28.44%
16,132 $1.96 Million
Q1 2018

May 03, 2018

BUY
$125.1 - $148.14 $620,370 - $734,626
4,959 Added 28.2%
22,542 $2.89 Million
Q4 2017

Feb 09, 2018

BUY
$131.22 - $143.62 $1.03 Million - $1.13 Million
7,874 Added 81.1%
17,583 $2.46 Million
Q3 2017

Nov 09, 2017

BUY
$129.47 - $135.38 $1.26 Million - $1.31 Million
9,709
9,709 $1.26 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.